An FDA panel has voted 3-14 that Abbott (ABT) has not found right dose for its irritable bowel...

|About: Abbott Laboratories (ABT)|By:, SA News Editor

An FDA panel has voted 3-14 that Abbott (ABT) has not found right dose for its irritable bowel syndrome drug Humira. Last week, FDA staff had questioned whether Humira had a real benefit for people with the disease who had already tried other treatments.